Study of methylation pattern of de Novo DNA methyltransferase genes and its correlation with DNA methylation pattern of RUNX3 in individuals with gastric cancer from northern region of Brazil

International Journal of Morphology

Volumn 25, Issue 4, 2007, Pages 817-824

  Lima, Eleonidas Moura ^a   Leal, Mariana Ferreira ^b   Motta, Fábio José Nascimento ^a   De Assumpção, Paulo Pimentel ^c   Harada, Maria Lúcia ^c   Smith, Marilia De Arruda Cardoso ^b   Burbano, Rommel Rodríguez ^c,d   Casartelli, Cacilda ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c FEDERAL UNIVERSITY OF PARÁ   (Brazil)

^d Departamento de Biologia   (Brazil)

Author keywords

de novo DNA methyltransferases; Gastric cancer; Methylation; RUNX3

Indexed keywords

EID: 42449085749     PISSN: 07179367     EISSN: 07179502     Source Type: Journal    
DOI: 10.4067/S0717-95022007000400022     Document Type: Article

References (47)

1. Antequera, F. & Bird, A. CpG islands. Exs., 64:169-85, 1993.
2. Baylin, S. & Bestor, T. H. Altered methylation patterns in cancer cell genomes: cause or consequence? Cancer Cell 1:299-305, 2002.
3. Baylin, S. B.; Herman, J. G.; Graff, J. R.; Vertino, P. M. & Issa, J. P. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv. Cancer Res., 72:141-96, 1998.
4. Bestor, T. Structure of mammalian DNA methyltransferase as deduced from the inferred amino acid sequence and direct studies of the protein. Biochem. Soc. Trans., 16:944-7, 1988.
5. Bird, A. DNA methylation patterns and epigenetic memory. Genes Dev., 16:6-21, 2002.
6. Catalano, V.; Labianca, R.; Beretta, G. D.; Gatta, G.; de Braud, F. & Van Cutsem, E. Gastric cancer. Crit. Rev. Oncol. Hematol., 54:209-41, 2005.
7. Chi, X.Z.; Yang, J.O.; Lee, K.Y.; Ito, K.; Sakakura, C.; Li, Q.L.; Kim, H.R.; Cha, E. J.; Lee, Y. H.; Kaneda, A.; Ushijima, T.; Kim, W. J.; Ito, Y. & Bae, S. C. RUNX3 suppresses gastric epithelial cell growth by inducing p21(WAF1/Cip1) expression in cooperation with transforming growth factor {beta}-activated SMAD. Mol. Cell. Biol., 25:8097-107, 2005.
8. Coffman, J. A. Runx transcription factors and the developmental balance between cell proliferation and differentiation. Cell. Biol. Int., 27:315-24, 2003.
9. Esteller, M. & Herman, J.G. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J. Pathol., 196:1-7, 2002.
10. Feng, X. H. & Derynck, R. Specificity and versatility in TGF-beta signaling through smads. Annu. Rev. Cell. Dev. Biol., 21:659-93, 2005.
11. Fujimoto, J.; Yasui, W.; Tahara, H.; Tahara, E.; Kudo, Y. & Yokozaki, H. DNA hypermethylation at the pS2 promoter region is associated with early stage of stomach carcinogenesis. Cancer Lett., 149:125-34, 2000.
12. Gardiner-Garden, M. & Frommer, M. CpG islands in vertebrate genomes. J. Mol. Biol., 196:261-82, 1987.
13. Gowher, H.; Liebert, K.; Hermann, A.; Xu, G. & Jeltsch, A. Mechanism of stimulation of catalytic activity of Dnmt3A and Dnmt3B DNA-(cytosine-C5)- methyltransferases by Dnmt3L. J. Biol. Chem. 280:13341-8, 2005.
14. Grace Goll, M. & Bestor, T. H. Eukaryotic cytosine methyltransferases. Annu. Rev. Biochem., 74:481-514, 2005.
15. Gruenbaum, Y.; Cedar, H. & Razin, A. Substrate and sequence specificity of a eukaryotic DNA methylase. Nature, 295:620-2, 1982.
16. Hata, K.; Okano, M.; Lei, H. & Li, E. Dnmt3L cooperates with the Dnmt3 family of de novo DNA methyltransferases to establish maternal imprints in mice. Development, 129:1983-93, 2002.
17. Hayatsu, H.; Wataya, Y.; Kai, K. & Iida, S. Reaction of sodium bisulfite with uracil, cytosine, and their derivatives. Biochemistry, 9:2858-65, 1970.
18. Herman, J.G.; Graff, J.R.; Myohanen, S.; Nelkin, B.D. & Baylin, S.B. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. U S A., 93:9821-6, 1996a.
19. Herman, J. G.; Jen, J.; Merlo, A. & Baylin, S.B. Hypermethylation- associated inactivation indicates a tumor suppressor role for p15INK4B. Cancer Res., 56:722-7, 1996b.
20. Hermann, A.; Gowher, H. & Jeltsch, A. Biochemistry and biology of mammalian DNA methyltransferases. Cell Mol. Life Sci., 61:2571-87, 2004.
21. INCA. Estimativa 2006: incidência câncer no Brasil. http://www.inca.org.br. Acessed November 12, 2005.
22. Kaneda, M.; Sado, T.; Hata, K.; Okano, M.; Tsujimoto, N.; Li, E. & Sasaki, H. Role of de novo DNA methyltransferases in initiation of genomic imprinting and X-chromosome inactivation. Cold Spring. Harb. Symp. Quant. Biol., 69:125-9, 2004.
23. Kim, T. Y.; Lee, H. J.; Hwang, K. S.; Lee, M.; Kim, J. W.; Bang, Y. J. & Kang, G. H. Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma. Lab. Invest., 84:479-84, 2004.
24. Laird, P. W.The power and the promise of DNA methylation markers. Nat. Rev. Cancer, 3:253-66, 2003.
25. Laurén, P. The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma. Acta Pathologica et Microbiologica Scandinava, 64:31-49, 1965.
26. Levanon, D.; Brenner, O.; Otto, F. & Groner, Y. Runx3 knockouts and stomach cancer. EMBO Rep., 4:560-4, 2003.
27. Li, E. Chromatin modification and epigenetic reprogramming in mammalian development. Nat. Rev. Genet., 3:662-73, 2002.
28. Li, L. C. & Dahiya, R. MethPrimer: designing primers for methylation PCRs. Bioinformatics, 18:1427-31, 2002.
29. Lima, E.M.; Araujo, J.J.; Harada, M.L.; Assumpcao, P.P.; Burbano, R.R. & Casartelli, C. Molecular study of the tumour suppressor gene PTEN in gastric adenocarcinoma in Brazil. Clin. Exp. Med., 5:129-32, 2005.
30. Lyko, F. Establishment and functional validation of a structural homology model for human DNA methyltransferase 1. Biochem. Biophys Res. Commun 306:558-63, 2003.
31. Miller, M. P. Tools for population genetic analyses [TFPGA] 1.3: A Windows program for the analysis of allozime and molecular population genetic data. Computer software distributed by author, 1997.
32. Okano, M.; Bell, D.W.; Haber, D.A. & Li, E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99:247-57, 1999.
33. Okano. M.; Xie, S. & Li, E. Dnmt2 is not required for de novo and maintenance methylation of viral DNA in embryonic stem cells. Nucleic Acids Res., 26:2536-40, 1998.
34. Rey, J. A.; Bello, M. J.; Jimenez-Lara, A.M.; Vaquero, J.; Kusak, M. E.; de Campos, J. M.; Sarasa, J. L. & Pestana, A. Loss of heterozygosity for distal markers on 22q in human gliomas. Int. J. Cancer, 51:703-6, 1992.
35. Rhee, I.; Bachman, K. E.; Park, B. H.; Jair, K.W.; Yen, R.W.; Schuebel, K. E.; Cui, H.; Feinberg, A. P.; Lengauer, C.; Kinzler, K.W.; Baylin, S. B.; & Vogelstein, B. DNMT1 and DNMT3b cooperate to silence genes in human cancer cells. Nature, 416:552-6, 2002.
36. Robertson, K. D.; Uzvolgyi, E.; Liang, G.; Talmadge, C.; Sumegi, J.; Gonzales, F. A. & Jones, P. A. The human DNA methyltransferases (DNMTs) 1, 3a and 3b: coordinate mRNA expression in normal tissues and overexpression in tumors. Nucleic Acids Res., 27:2291-8, 1999.
37. Sato, M.; Horio, Y.; Sekido, Y.; Minna, J.D.; Shimokata, K. & Hasegawa, Y. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines. Oncogene, 21:4822-9, 2002.
38. Shapiro, R.; Cohen, B. & Servis, R.E. Specific deamination of RNA by sodium bisulphite. Nature, 227:1047-8, 1970.
39. Siedlecki, P.; Boy, R.G.; Comagic, S.; Schirrmacher, R.; Wiessler, M.; Zielenkiewicz, P.; Suhai, S.; Rennert, J.; Coffman, J. A.; Mushegian, A. R. & Robertson, A. J. The evolution of Runx genes I. A comparative study of sequences from phylogenetically diverse model organisms. BMC Evol. Biol., 3:4, 2003.
40. Stewart, B. W. & Kleihues, P. (Eds) World Cancer Report. IARCPress, Lyon, p.35, 2003.
41. Venter, J. C.; Adams, M. D.; Myers, E.W.; Li, P. W.; Mural, R. J.; Sutton, G. G. & Smith, H.O. The sequence of the human genome. Science, 291:1304-51, 2001.
42. Tahara, E. Genetic pathways of two types of gastric cancer. IARC Sci. Publ.,:327-49, 2004.
43. Tamura, G.: Genetic and epigenetic alterations of tumor suppressor and tumor-related genes in gastric cancer. Histol. Histopathol., 17:323-9, 2002.
44. Xie, S.; Wang, Z.; Okano, M.; Nogami, M.; Li, Y.; He, W.W.; Okumura, K. & Li, E. Cloning, expression and chromosome locations of the human DNMT3 gene family. Gene, 236:87-95, 1999.
45. Zhang, Y.J.; Ahsan, H.; Chen, Y.; Lunn, R.M.; Wang, L.Y.; Chen, S.Y.; Lee, P.H.; Chen, C.J. & Santella, R.M. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Mol. Carcinog., 35:85-92, 2002.
46. Waki, T.; Tamura, G.; Sato, M.; Terashima, M.; Nishizuka, S. & Motoyama, T. Promoter methylation status of DAP-kinase and RUNX3 genes in neoplastic and non-neoplastic gastric epithelia. Cancer Sci., 94:360-4, 2003.
47. Wang, R.Y.; Gehrke, C.W. & Ehrlich, M. Comparison of bisulfite modification of 5-methyldeoxycytidine and deoxycytidine residues. Nucleic Acids Res., 8:4777-90, 1980.